can doctors still prescribe compounded semaglutide FDA issues warning about some versions of for diabetes, weight loss Compounded Semaglutide Safety: What You

Visual presentation of new weight loss medicine trial results can supplement standard published reports by condensing substantial amounts of complex technical information in an easily understood format that can potentially yield new study insights.

Learn about Tresiba (insulin degludec), a once-daily, long-acting basal insulin for patients over 1 year of age with type 1 or type 2 diabetes

Learn the 2026 eligibility rules for donor centers and why you must disclose if you take Ozempic.

The fascinating history of the GLP-1 drugs- Ozempic, Wegovy, and Mounjaro.

With Nutrium Care, employers can adopt strategies for sustainable, equitable GLP-1 coverage or exclusion

states and two other countries.